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Consumer demand for high and consistent quality beef has lead to significant changes in 
the U.S. beef production and marketing systems. Currently, the majority of U.S fed cattle 
are marketed through a grid marketing system (Forristall et al., 2002; Tess, 2002), which 
rewards/penalizes producers based on the USDA quality and yield grades classification 
for carcass beef (United States Department of Agriculture, 1997). The amount and 
distribution of fat (adipose tissue) plays a central role in this classification system. Due to 
obvious health reasons, meat with excessive external fat (subcutaneous fat) is less 
appealing to the consumer and has a low grading score. To increase marketability, 
excessive external fat is usually trimmed off during slaughter at the expense of total 
carcass yield. This has resulted in a significant loss to the beef industry, and was 
estimated to be around $111.99 per steer/heifer slaughtered in 1991 (Savell, 2006). 
However, deposition of fat within the muscle (intramuscular fat/marbling) is a highly 
desirable carcass trait as it increases the tenderness and eating quality of meat. Marbled 
meat is graded high and has more value (Tan et al., 2006). In view of all the above 
information it is clear that the quality and value of beef is largely dependent on 
adipogenesis. 
 
Adipogenesis is a complex physiologic process influenced by different factors such as 
genetics, environment, breed, age, sex, nutrition and management practices (Pyatt and 
Berger, 2005). Genetic factors significantly influence beef carcass composition and 
quality traits like marbling, fat thickness, tenderness, juiciness and flavor since these 
traits are moderate to highly heritable. Traditionally, selective breeding of animals have 
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been used to generate superior progeny exhibiting desirable traits of economical 
importance. Information on DNA markers and techniques like marker assisted selection 
along with other pedigree and phenotypic information make it possible to evaluate and 
exploit the genetic merit of animals (Bindon, 2004; Burrow et al., 2001). In order to 
achieve this it is essential to gain an in-depth knowledge of the genetic basis of 
adipogenesis and identify significant molecular factors that influence body fat 
distribution and deposition. Mammalian adipogenesis at the molecular level has been 
studied extensively during the last three decades using human and mouse models. Studies 
on ruminant adipogenesis are limited to very few reports on some key transcription 
factors and regulators.  This review mainly focuses on growth and development of 
mammalian white adipose tissue and its molecular control. 
 
Adipose Organ  
Adipose tissue, commonly called fat, is a specialized connective tissue present in all 
mammalian organisms and is characterized by the presence of lipid filled adipocytes and 
associated stromal vascular cells held in a matrix of collagen fibers. Adipose tissue 
occurs in two different forms in an animal’s body: White Adipose Tissue (WAT) and 
Brown Adipose Tissue (BAT). The major physiological role of WAT is storage of energy 
in the form of triglycerides (lipids) during periods of nutritional excess and its release 
during periods of food deprivation. The distinguishing feature of WAT is the presence of 
a single, large lipid droplet in the cytoplasm (unilocular) of the adipocytes. BAT is 
characterized by the presence of multiple, small lipid droplets in their cytoplasm 
(multilocular) (Cinti, 2005; Greenwood and Johnson, 1983). BAT primarily functions as 
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a thermogenic organ and serves to provide thermal and energy balance through heat 
production especially in neonatal and hibernating animals (Cannon and Nedergaard, 
2004). 
 
With the presence of two major cell types organized in two tissues (WAT and BAT) and 
the stromal vascular cells, adipose depots inside an animals body forms the adipose organ 
(Cinti, 2005). Studies conducted during last couple of decades suggest that the adipose 
organ secretes a variety of molecules that controls energy homeostasis, immune response, 
myocardial contraction, fertility, reproduction, hemopoiesis vascular hemodynamics, 
growth and differentiation (Morrison and Farmer, 1999).  This review mainly focuses on 
growth and differentiation of white adipose tissue. 
 
Adipose tissue occurs in multiple dispersed anatomical locations in the body. Based on 
the anatomical distribution, total body adipose tissue can be grouped under two major 
classes: subcutaneous and internal. Subcutaneous adipose tissue can be defined as the 
layer of adipose tissue found between the dermis and the aponeuroses and fasciae of 
muscles. Internal adipose tissue can be further classified into visceral adipose tissue 
(within the chest, abdomen and pelvis) and non-visceral internal adipose tissue. The non-
visceral internal adipose tissue includes intramuscular adipose tissue, intermuscular 
adipose tissue, paraosseal adipose tissue, orbital adipose tissue and any other aberrant 
adipose tissue depots (Hausman et al., 2001; Shen et al., 2003; United States Department 
of Agriculture, 1997).  
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Mature adipocytes constitute the major cell population present in adipose tissue.  The 
remaining fraction includes blood cells, endothelial cells, pericytes, adipose precursor 
cells of varying degree of differentiation including non-lipid filled mesenchymal cells 
(Ailhaud et al., 1992; Geloen et al., 1989; Hausman et al., 2001). Mature adipocytes show 
a bimodal distribution of their diameters. Based on this bimodal distribution the 
adipocytes can be divided into two fractions: classic adipocyte fraction (35-150µm 
diameter) and a very small adipocyte fraction (8-35µm diameter) (DeMartinis and 
Francendese, 1982). Eventhough the functional significance of this bimodal distribution 
is not fully understood, the existing knowledge suggests that the very small adipocyte 
fraction indicates hyperplastic growth of adult adipose tissue. 
 
Adipogenesis 
Development of adipose tissue from its precursor cells is known as adipogenesis. 
Adipogenesis occurs throughout the life time of an animal. Increase in adipose tissue 
mass occurs through hyperplasia as well as hypertrophy.  
 
Adipose tissue is considered to be a specialized form of loose connective tissue. All types 
of connective tissues present in an animal’s body arise from the embryonic mesoderm 
and is characterized by a highly vascular and complex matrix of extracellular fibers 
(collagen and elastic), amorphous ground substance and a population of connective tissue 
cells. During early embryonic development, the mesoderm and neuroectoderm give rise 
to a loose connective tissue network called mesenchyme. This mesenchyme contains star 
shaped cells which are considered to be the ancestors of the cellular population of adult 
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connective tissue including the fibroblast, chondroblast, osteoblast, odontoblast, reticular 
cells and adipoblasts (Goldberg and Raninovitch, 1983). Even though the mesenchymal 
lineage of adipose tissue was suggested in 1871 by Fleming, convincing evidence 
supporting the mesenchymal lineage arose only during 1920s and 1930s. There after, 
adipose tissue has been considered as an independent organ (Greenwood and Johnson, 
1983). Adipocytes constitute the major cell population present in adipose tissue. The 
remaining portion includes blood cells, endothelial cells, pericytes, adipose precursor 
cells of varying degree of differentiation and interstitial cells/non-lipid filled 
mesenchymal cells (Ailhaud et al., 1992; Geloen et al., 1989). As explained above, these 
mesenchymal cells go through a determination step and change to adipoblasts and several 
other distinct lineages. Adipoblasts also go through commitment and get converted to 
pre-adipocytes. It is not certain whether the non-lipid filled mesenchymal cells present in 
prenatal and adult adipose tissue represent both adipoblasts and pre-adipocytes or pre-
adipocytes alone (Ailhaud et al., 1992). 
 
Embryonic development 
Studies conducted by Slavin (1979) on embryonic and early postnatal adipose tissue 
development and differentiation in mouse showed that adipocyte precursor cells appeared 
on developing inguinal fat pad between days 17 to 19 prenatally and on epididymal, 
mesenteric and mesometrial regions during one to three days postnatally. These light and 
electron microscopic studies clearly established that adipocytes differentiate from a pool 
of fibroblast like mesenchymal cells.  Embryonic development of WAT has been 
subsequently studied in a variety of species including human, pig, rat and mouse 
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(Ailhaud et al., 1992; Gregorie et al., 1998; Novakofski, 2004; Poissonnet et al., 1988). 
These studies indicated that formation of adipose cells from mesenchymal tissue begins 
during mid to late gestation. In case of human embryos, clusters of white adipose tissue 
start appearing earlier, during the second trimester of gestation at various anatomical sites 
(Ailhaud et al., 1992; Poissonnet et al., 1988). These studies along with others conducted 
on cattle, indicate that the chronology of WAT appearance during embryonic and 
postnatal periods depend strictly on the species and the anatomical location (Gregorie et 
al., 1998; Hood and Allen, 1975; Robelin, 1985; Robelin, 1986).  
 
During initial stages of development, dense clusters of mesenchymal cells appear near 
large blood vessels. These mesenchymal clusters transform into primitive fat cell clusters 
and the cluster size gradually increases with fetal age. In both human and pig 
embryogenesis, this cluster development is accompanied by the development of an 
extensive network of capillaries (Ailhaud et al., 1992). 
 
Postnatal development 
Rodent models (rats and mouse) have been extensively used to study the postnatal 
development of WAT. Initial works on postnatal development and cellularity of WAT 
conducted in rats, as well as normal and obese mice, indicated that the number of 
adipocytes showed a steady increase immediately after birth and continued that pattern 
until four months of age (Greenwood and Hirsch, 1974; Hirsch and Han, 1969; 
Lemonnier, 1972). However, after four months, a steady increase in adipose tissue was 
observed only in obese animals (Lemonnier, 1972). Lemonnier (1972), in his pioneering 
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work on effect of diet on fat cell number and size, reported that until four months of age 
adipose tissue growth occurred through an increase in cell number ( hyperplasia) and size 
( hypertrophy ) both in normal and obese mouse. In normal adult mouse (5 to 12 months 
of age) the increase in fat cell mass was associated with an increase in cell size but not in 
cell number, while in obese mice, there was a steady increase in both cell number and 
size. The experimental techniques used in a majority of these studies considered only 
cells which were completely filled with lipid droplets and hence were not accurate 
enough to detect modest changes in cell number. So these studies could not give a true 
estimate of the developmental potential of various adipose tissue depots. The hyperplastic 
development of adipose tissue in adult animals has been studied extensively during the 
last three decades and results indicate that precursor cells present in mature adipose tissue 
have life long potential to make new fat cells (Ailhaud et al., 1992). 
 
In vitro models of adipocyte differentiation 
Most of what is known about WAT differentiation originated from in vitro studies 
conducted in embryonic and adipose tissue derived primary cell cultures and cell lines. 
Two classes of cell lines are currently available for studying various aspects of adipose 
differentiation: (1) Multipotent stem cell lines that have not been committed to the 
adipocyte lineage (10T1/2, CHEF/18, Balb/c 3T3) and (2) Pre-adipocyte cell lines that 
have already been committed to the adipocyte lineage (3T3 L1, 3T3-F442A, Ob1771) 
(Ailhaud et al., 1992; Gregorie et al., 1998; MacDougald and Lane, 1995b; Novakofski, 
2004; Otto and Lane, 2005). 3T3 L1 and 3T3-F442A are the most extensively 
characterized and frequently used models for studying adipocyte biology. Green and 
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Meuth (1974) observed that a fibroblast clonal line (3T3) established from disaggregated 
Swiss mouse embryo cells when grown in culture attained confluence and remained 
viable in a resting stage for long periods. At confluence, few of these cells showed small 
lipid droplets in their cytoplasm. These findings resulted in a series of experiments to 
explore the adipogenic potential of 3T3 lines and the development of the most widely 
used clonal line, 3T3 L1 (Green and Meuth, 1974; Green and Kehinde, 1974; Todaro and 
Green, 1963).  
 
One of the major disadvantages of these immortalized cell lines is their aneuploid nature. 
Researchers often had to verify their findings using primary cultures derived from diploid 
pre-adipocytes (adult stem cells) isolated from adipose tissue and to a limited extend 
using transgenic animals (Bluher, 2005; Cornelius et al., 1994). Over the past several 
years, primary pre-adipocyte cultures have been successfully developed from the mature 
adipose tissue of rat, mouse, human, pig, sheep, cattle and chicken (Bjorntorp et al., 
1980; Gregoire et al., 1992; Hausman and Poulos, 2004; Rodriguez et al., 2004; Soret et 
al., 1999; Torii et al., 1998; Wu et al., 2000). These primary cultures were developed 
from fibroblast like interstitial cells isolated from the vascular stroma of different adipose 
depots commonly referred to as the Stromal Vascular Cells (SVCs). As will be explained 
later in this chapter, these precursor cells originally represent undifferentiated 
mesenchymal cells (adipoblasts/pre-adipocytes) (Ailhaud et al., 1992).  
 
Irrespective of their nature, in vitro differentiated adipocytes display several 
characteristics similar to adipocytes inside the body. Faithfulness of primary cultures and 
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cell lines, which are used as model systems to study adipose tissue development, has been 
demonstrated by in vivo cell transplantation studies. When injected into anatomical sites 
devoid of adipose tissue, 3T3-F442A and adipose tissue derived pre-adipocytes 
developed into normal fat pads that are histologically indistinguishable from WAT 
(Ailhaud et al., 1992; Cornelius et al., 1994; Green and Kehinde, 1979; Sottile and 
Seuwen, 2000). This evidence along with evidence from several biochemical studies 
suggests that adipocyte differentiation occurs through similar mechanisms in vitro and in 
vivo (MacDougald and Lane, 1995b).  
 
Adipocyte differentiation: Sequential events 
The key events during adipocyte differentiation were identified exclusively using pre-
adipocyte model systems. These sequential events can be divided into four phases:. 
commitment, growth arrest, mitotic clonal expansion and terminal differentiation.  
 
Commitment 
The process of development of specialized cells from the embryonic stem cells is known 
as differentiation. Differentiating cells show overt changes in cellular biochemistry and 
function. Before differentiating into specific phenotypes, embryonic stem cells go 
through a phase of commitment. The commitment process can be divided into two 
distinct phases: 1) specification and 2) determination. During specification, cells make a 
developmental choice and follow a particular path of differentiation if left in their normal 
environment. Cells at this stage can be reversed to the previous stage. Once the cells go 
through the phase of determination, they can differentiate autonomously even if they are 
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placed in another region of the embryo. At this stage, the commitment becomes 
irreversible (Gilbert, 2000). Even though their fate has been restricted to specific 
lineages, the committed cells can not be phenotypically distinguished from the 
uncommitted cells.  
 
Stem cells by definition are “population of cells possessing self renewal capacity, long 
term viability and multi lineage potential” (Zuk et al., 2002). The self renewal and 
differentiation ability of stem cells vary depending on the stage of development and 
based on that stage stem cells can be classified into totipotent, pluripotent, multipotent or 
unipotent. Cells at pre-blastocyst stage of embryonic development are referred to as 
totipotent stem cells. These cells are unspecialized, but they can transform into any type 
of cells during development. After the blastocyst stage, cells begin to specialize and stem 
cells present in the embryo at this stage are referred to as pluripotent. As the embryo 
grows, differentiation potential of cells gets restricted to few cell lineages and the cells at 
this stage are commonly designated as multipotent stem cells. Multipotent stem cells 
usually reside in tissues among already differentiated cells, but they retain their capacity 
to differentiate into several related lineages (Robert, 2004). It is well established that the 
neonatal and adult mammalian adipose tissue contains multipotent stem cells and 
progenitor cells that can differentiate into adipogenic,osteogenic, chondrogenic, 
myogenic, neurogenic, endothelial, hematopoietic and hepatic lineages (Cousin et al., 
2003; Miranville et al., 2004; Seo et al., 2005; Zuk et al., 2002). These cells are popularly 
known as SVCs. When exposed to appropriate signal, SVCs undergo the determination 
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phase and get converted to unipotent progenitor cells which in turn differentiate into 
corresponding cell types. 
 
Even though none of the regulatory mechanisms that commit stem cells to adipocyte 
lineage have been identified by in vivo studies, several recent in vitro studies reported 
that Bone Morphogenic Proteins (BMPs), members of the transforming growth factor 
type β superfamily, play a significant role in committing the pluripotent embryonic 
mesenchymal cell lines to adipocyte and osteoblast lineage (Chen et al., 1998; Fux et al., 
2004; Sottile and Seuwen, 2000; Tang et al., 2004). Studies have also showed that BMPs 
co-operate with members of the CCAAT enhancer binding protein (C/EBPs) family and 
the level of expression of these proteins direct the pluripotent cells to the 
adipocyte/osteoblast lineage (Fux et al., 2004). Once determined, the pre-adipocyte cells 
go through a phase of growth arrest and clonal expansion and finally differentiate into 
mature adipocytes.  
 
Growth arrest  
Pre-adipocytes at confluence go through a stage of growth arrest when cells become 
density inhibited and stay at the G0/G1 cell cycle boundary. This growth arrest is 
considered to be a pre-requisite for subsequent events happening during in vitro 
differentiation (Gregorie et al., 1998; Otto and Lane, 2005). Growth arrested pre-
adipocytes express high concentrations of pre-adipocyte factor-1 (Pref-1), a 
transmembrane epidermal growth factor-like domain- containing-protein that maintains 
the pre-adipocytes in undifferentiated state (MacDougald and Lane, 1995a; Smas et al., 
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1998). The continued inhibition of Pref-1 expression at the beginning and through the 
terminal phase of differentiation were found to be necessary for the activation of several 
key adipogenic transcription factors like CEBPα and PPARγ (Smas et al., 1998).The 
inhibitory effects of Pref-1 on adipogenesis have been confirmed by its constitutive 
expression in 3T3-L1 pre-adipocytes (Smas and Sul, 1993). Another similar molecular 
switch that maintains pre-adipocytes in the undifferentiated stage is Wnt signaling 
(Gregoire, 2001). The Wnt signaling pathway also regulates differentiation of pre-
adipocytes through inhibition of CEBPα and PPARγ.  Eventhough few other pre-
adipocyte associated adipogenic inhibitors have been described, the exact regulatory 
pathways are yet to be identified.  
  
Mitotic clonal expansion. 
To continue through the differentiation program, growth arrested pre-adipocytes must be 
exposed to an appropriate combination of mitogenic and adipogenic stimuli (Gregorie et 
al., 1998; Otto and Lane, 2005).  Depending on source (species, age, depot) and type (cell 
lines/primary cultures/ embryonic/adult), pre-adipocyte cultures vary considerably in 
their responsiveness to external stimuli (inducers) (Gregoire, 2001; Gregorie et al., 1998).  
For commonly used pre-adipocyte cell lines like 3T3-L1, 3T3-F442A, C3H10T1 etc., a 
standard mixture containing supra-physiological concentrations of insulin, 
glucocorticoides (Dexamethasone), cAMP elevating agents (Isobutyl Methyl Xanthine) 
and Fetal Bovine Serum (FBS) has been proven to be ideal.  However, for the 
differentiation of primary cell cultures, in addition to the above mentioned inducers it 
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may be necessary to include other agents such as fatty acids, prostaglandins, antidiabetic 
drugs like thiazolidinedions and/or other hormones, depending on species/source of cells. 
 
On exposure to the most suitable combination of inducers, growth arrested cells re-enter 
cell cycle and undergo few more rounds of cell division, known as the mitotic clonal 
expansion (Gregoire, 2001; Gregorie et al., 1998; Otto and Lane, 2005). In 3T3-L1 cells, 
the transient DNA synthesis associated with mitotic clonal expansion starts around 18h 
after the addition of inducers. At the end of this phase, cells enter a distinct phase in the 
G1 growth arrest stage called GD (Scott et al., 1982). Cells at this stage are characterized 
by their ability to undergo differentiation without DNA synthesis. 
 
Conflicting reports exist regarding the necessity of mitotic clonal expansion prior to 
terminal differentiation (Entenmann and Hauner, 1996). However, the majority of studies 
show that blocking cell cycle progression after induction with rapamycin (Yeh et al., 
1995) or aphidicolin (Otto and Lane, 2005; Reichert and Eick, 1999) completely prevent 
mitotic clonal expansion, expression of adipocyte markers and triglyceride accumulation. 
The most appealing evidence for a need for mitotic clonal expansion prior to terminal 
differentiation comes from studies on C/EBPβ depletion in 3T3-L1 pre-adipocytes (Tang 
et al., 2003; Zhang et al., 2004).  C/EBPβ is a crucial transcription factor expressed very 
early during induction (2-4h). This protein reaches peak concentrations around 24h post 
induction (Tang et al., 2003). It localizes at the centromere at the beginning of clonal 
expansion and acquires DNA binding activity. At this stage C/EBPβ transcriptionally 
activates two important adipogenic transcriptional factors C/EBPα and PPARγ (Lane et 
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al., 1999). During clonal expansion, the expression of C/EBPβ begins to decline and the 
levels of C/EBPα and PPARγ slowly increase.  These transcription factors act as 
terminators of mitotic clonal expansion (Yang et al., 2007). Disruption of C/EBPβ results 
in complete prevention of mitotic clonal expansion and adipogenesis indicating that this 
protein is crucial for both these processes (Tang et al., 2003). In addition to C/EBPs and 
PPARs, adipocyte determination and differentiation factor/sterol regulatory element 
binding proteins (ADD/SREBP) family of transcription factors are also expressed very 
early during adipocyte differentiation (Gregorie et al., 1998) Other proteins expressed 
during clonal expansion phase include proteins that are mainly associated with the cell 
cycle progression like cyclins, cyclin dependent kinases, cMyc proteins and E2F family 
of transcription factors (Gregorie et al., 1998). Accurate steps and events associated with 
this very early phase of clonal expansion are yet to be fully identified. 
 
Marked changes in cellular morphology of pre-adipocytes from fibroblast-like cells to 
round adipocytes occur during clonal expansion and the initial phases of adipogenesis. 
These morphological changes occur as a result of alterations in the extracellular matrix 
(ECM) components and the rearrangement of the cytoskeletal network. These structural 
changes are essential for the communication between ECM and the nuclear matrix and 
acts as a signal for the activation of adipogenic transcription factors and genes necessary 
for terminal differentiation.  During the first 2-3 days of differentiation, a gradual 
decrease occurs in the biosynthesis of macro and micro elements of the cytoskeleton such 
as actin, tubulin, vimentin, vinculin, and tropomyosin (Brandes et al., 1993; Gregorie et 
al., 1998; Rodriguez Fernandez and Ben-Ze'ev, 1989; Smas and Sul, 1995; Spiegelman 
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and Farmer, 1982). Ninety to 95% decrease in the synthesis of actin and tubulin is 
considered to be a key characteristic during this time period (Spiegelman and Farmer, 
1982). Along with cytoskeletal components, expression of ECM components is also 
highly regulated during adipocyte differentiation. Initially, the fibronectin rich ECM of 
the pre-adipocytes gets converted to an adipocyte basal lamina. Consequent to this, 
fibronectin, collagen type I, type III and integrin expression decreases and the expression 
of collagen type IV and entactin (protein of basal lamina) increases (Gregorie et al., 1998; 
Smas and Sul, 1995).  
 
Terminal Differentiation 
Cells that enter the distinct growth arrest stage of GD (Scott et al., 1982) become 
committed to go trough terminal differentiation and express the adipogenic differentiation 
markers.  During terminal differentiation cells become spherical and start accumulating 
multiple small lipid droplets in their cytoplasm. Around 5-7 days post differentiation, the 
smaller droplets coalesce to form 2 or 3 bigger droplets. These droplets almost 
completely fill the cytoplasm and push the nucleus towards one side. C/EBPα and PPARγ 
through auto-activation and cross regulation, maintain the cells in terminally 
differentiated stage. These proteins work synergistically and activate transcription of 
hundreds of adipose specific genes (Gregorie et al., 1998; Otto and Lane, 2005; 
Rangwala and Lazar, 2000; Rosen and Spiegelman, 2000). Transcriptional regulation of 
adipogenesis by these proteins is explained in the next section. Some of the adipose 
specific genes activated by C/EBPα and PPARγ include adipocyte type fatty acid binding 
protein, fatty acid translocase, perilipin, lipoprotein lipase, glucose transport protein 4, 
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glycerol-3-phosphate dehydrogenase, acetyl-CoA oxidase ATP citrate lyase, malic 
enzyme, acetyl-CoA carboxylase, stearoyl-CoA desaturase, glycerol-3-phosphate acyl 
transferase, fatty acid synthase and phosphoenolpyruvate carboxykinase (Ailhaud et al., 
1992; Gregorie et al., 1998; MacDougald and Lane, 1995a; Otto and Lane, 2005; Rosen 
and Spiegelman, 2000). 
 
Transcriptional control of adipogenesis 
Complex molecular mechanisms that control adipogenesis are regulated mainly by three 
groups of transcription factors: peroxisome proliferator-activated receptors (PPARs), 
CCAAT enhancer binding proteins (C/EBPs) and adipocyte determination and 
differentiation–dependent factors/sterol regulatory element binding proteins 
(ADDs/SREBPs) (Debril et al., 2001; Rosen and Spiegelman, 2000). All these factors 
function synergistically to control adipogenesis in vivo. Eventhough these factors can 
independently induce adipogenesis in cultured pre-adipocytes, their interdependence and 
co-regulation are indispensable for maintenance of differentiation.  
 
Peroxisome Proliferator Activated Receptors (PPARs) 
Peroxisome proliferator-activated receptors (PPARs) comprise of a subfamily of 
transcription factors that belong to the nuclear hormone receptor super family. Three 
distinct members of this subfamily have been identified so far: PPARα, PPARγ and 
PPARδ(Berger and Moller, 2002; Debril et al., 2001; Fajas et al., 2001; Matsusue et al., 
2004; Mueller et al., 2002). PPAR α, the first identified PPAR, was cloned from rodent 
liver and was recognized as a peroxisome proliferating agent and thus the subfamily was 
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named as PPARs (Debril et al., 2001; Issemann and Green, 1990). Members of PPAR 
subfamily are characterized by three major structural and functional domains: N-terminal 
domain (AF-1), DNA binding domain (DBD) and ligand binding domain (LBD) (Debril 
et al., 2001; Houseknecht et al., 2002). PPARs heterodimerize with another member of 
the nuclear hormone receptor superfamily, retinoid X receptor (RXR), and control 
transcription of several target genes involved in a multitude of physiological processes. 
The DBD of PPARs recognizes two core hexanucleotide repeats on target genes which 
are spaced by an adenine nucleotide (5’AGGNCA A   AGGTCA3’). These recognition 
motifs on target genes are called PPAR response elements (PPREs) (Desvergne and 
Wahli, 1999). Various isotypes and isoforms of PPARs are expressed in different tissues 
and often times these isotypes show patterns of co-expression. Expression patterns of 
these isotypes have been studied extensively in human, mouse and xenopus to reveal their 
functional and biological significance. It has been reported that in adult mammals PPARα 
is expressed at high levels in cells with higher mitochondrial and peroxisomal beta 
oxidation like cardiomyocytes, cells of the kidney proximal tubules and enterocytes at the 
top of the intestinal villi (Desvergne and Wahli, 1999; Semple et al., 2006). PPARδ is 
abundantly expressed in all adult tissues at higher levels as compared to the other two 
isotypes (Desvergne and Wahli, 1999; Semple et al., 2006). In contrast to PPARα and 
PPARδ, PPARγ expression is restricted to few tissues including white adipose tissue 
(WAT), brown adipose tissue(BAT), colon, cecum, spleen, Payer’s patches, retina, heart, 
liver and skeletal muscle. Among these tissues, WAT and BAT were observed to be the 
major sites of expression (Debril et al., 2001; Desvergne and Wahli, 1999; Semple et al., 
2006). Three major isoforms of PPARγ (PPARγ1, γ2 and γ3) have been observed in most 
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mammalian species generated mainly by alternative promoter usage and alternative 
splicing (Rosen and Spiegelman, 2000). Among the three, PPARγ2 expression is 
restricted mainly to WAT (Mueller et al., 2002; Rosen and Spiegelman, 2000). Adipose 
tissue specific expression pattern along with the information from loss of function and 
gain of function experiments have demonstrated that PPARγ plays a pivotal role in 
adipose tissue growth and differentiation (Debril et al., 2001; Mueller et al., 2002; Rosen 
and Spiegelman, 2000).  
 
PPARγ activation, a major initial event during adipocyte proliferation and differentiation, 
was found to be regulated by numerous factors including phosphorylation, lipophillic 
ligands, activation/inhibition of coactivators/corepressors (Farmer, 2005; Houseknecht et 
al., 2002) and adipocyte-specific and other transcription factors. Ligand activation and 
subsequent recruitment of certain co-activators was suggested to be the most important 
mode of control among those listed above (Debril et al., 2001; Farmer, 2005; 
Houseknecht et al., 2002).  Fatty acids, eicosanoids, prostaglandins (15-PGJ2) and α1-
antitrypsin are the common naturally occurring ligands. Several synthetic ligands of 
PPARγ have also been identified over the past decade and include anti-diabetic drugs like 
thiazolidinediones (TZDs-roziglitazone, troglitazone, KRP297 etc.) and non-
thiazolidinediones like Isoxazolidinedione (JTT-501, GW-7845, GW-0207 ect.) 
(reviewed in (Houseknecht et al., 2002)). Eventhough a number of natural and synthetic 
ligands that can initiate adipogenesis have been identified, a true endogenous ligand or a 
pathway that can activate the release of a true endogenous ligand is yet to be identified 
(Houseknecht et al., 2002). 
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Binding of ligands to the large binding pocket formed by 13 α-helices and a 4 strand β-
sheet in the LBD leads to a conformational change in the PPARγ protein (Nolte et al., 
1998). This ligand bound PPARγ heterodimerizes with RXR and activates several distinct 
cofactors in a ligand dependent manner, which initiates the transcription of hundreds of 
adipose specific genes by binding to the PPREs present on the regulatory region of these 
target genes (Debril et al., 2001; Houseknecht et al., 2002; Nolte et al., 1998). RXR, 
eventhough not an adipocyte specific transcription factor, is considered to be one of the 
key regulators of adipogenesis since it is the obligate heterodimeric partner of PPARγ 
(Debril et al., 2001). Several important genes involved in fatty acid metabolism, transport 
and storage carry functional PPREs in their regulatory regions. Few examples include 
adipocyte type fatty acid binding protein, phosphoenol pyruvate carboxykinase, Acyl 
CoA synthetase, fatty acid transpoet protein 1, lipoprotein lipase, fatty acid translocase 
and stearoyl CoA desaturase (Debril et al., 2001; Desvergne and Wahli, 1999). PPARγ 
can activate the uptake of its own ligands like fatty acids and thus initiate/maintain pre-
adipocyte proliferation and differentiation by a positive feed back control involving 
PPARγ and its target genes (Debril et al., 2001) 
 
PPARγ expression is also regulated by members of the C/EBP and SREBP family of 
transcription factors. The activation and regulation of PPARγ by C/EBP and SREBP are 
discussed in the next section.  
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CCAAT/enhancer binding proteins (C/EBPs) 
CCAAT/enhancer binding proteins (C/EBPs) belong to a family of transcription factors 
that bind to the CCAAT box motif present on several gene promoters. These proteins are 
characterized by a highly conserved basic leucine zipper (bZIP) DNA binding and 
dimerization domain (Ramji and Foka, 2002).The basic-amino acid rich portion of the 
bZIP domain binds to the CCAAT box motif on target genes and the leucine zipper 
serves as the dimerization domain for the homodimer and heterodeimer formation . Six 
members of this family, C/EBPα, β, γ, δ, ε and ζ, have been identified so far in several 
species including human, mouse, rat, bovine, ovine, hamster and chicken (Ramji and 
Foka, 2002). All members except C/EBPζ can homodimerize/heterodimerize with each 
other and bind to regulatory regions in the target genes. Eventhough C/EBPζ readily 
heterodimerizes with all other members using its highly conserved leucine zipper, such 
heterodimers do not bind to the CCAAT motif. Instead, they bind to a completely 
different recognition sequence (PuPuPuTGCAAT(A/C)CCC, wher Pu is a purine) on the 
target genes . Hence, C/EBPζ is considered to be a potent inhibitor of all other CEBPs 
(Hamm et al., 2001; Ramji and Foka, 2002; Rosen and Spiegelman, 2000; Wu et al., 
1996).  
 
Among the various isotypes, C/EBPα, β, δ and ζ play important regulatory roles during 
adipogenesis. Distinct temporal patterns of expression of CEBPs start with a relatively 
low level of expression of C/EBPζ in confluent pre-adipocytes. As explained earlier, 
differentiation of confluent pre-adipocytes can be induced by insulin, glucocorticoides 
(dexamethasone), cAMP elevating agents (IBMX) and FBS. Following induction, the 
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cells re-enter the cell cycle and go through few more rounds of mitosis called clonal 
expansion. At this very early phase (zero to 48 h of differentiation), glucocorticoides and 
cAMP elevating agents present in the media induce a rapid and transient expression of 
C/EBPβ and δ (Otto and Lane, 2005). Transcriptional activation of C/EBPβ by cAMP 
occurs as a result of phosphorylation and activation of a protein named cAMP response 
element binding protein (CREB) and its binding to the cAMP responsive element-like cis 
regulatory sequences on C/EBPβ gene (Otto and Lane, 2005).  These proteins then set off 
the expression of two important adipogenic transcription factors: C/EBPα and PPARγ2. 
Since these proteins are the first to appear in differentiating pre-adipocytes and are 
implicated in the expression of C/EBPα and PPARγ, they are considered to be the key 
initial regulators of the differentiation process (Darlington et al., 1998; Ramji and Foka, 
2002; Rangwala and Lazar, 2000). As differentiation advances C/EBPβ and δ expression 
begin to decline and C/EBPα and PPARγ expression slowly increases and at the end of 
mitotic clonal expansion C/EBPα reaches its peak concentration (Lane et al., 1999). 
Thereafter, C/EBPα and PPARγ stays elevated throughout the entire differentiation 
program (Lane et al., 1999; Ramji and Foka, 2002). C/EBPα and PPARγ maintain high 
concentrations through the entire differentiation process by auto-activation and cross-
activation of each other’s expression through a positive feedback loop. Subsequent to 
their peak expression, each of these proteins independently activates hundreds of adipose-
specific genes and governs the cascade leading to terminal differentiation (Hamm et al., 
2001; Lane et al., 1999; Otto and Lane, 2005; Ramji and Foka, 2002). 
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Another expression event in this sequence is the expression of C/EBPζ, which is 
expressed in lower concentrations in pre-adipocytes and subsequently goes down to 
undetectable levels as the differentiation starts (0h) (Darlington et al., 1998; Rosen and 
Spiegelman, 2000). However, its expression returns to relatively higher levels four to five 
days after the onset of differentiation and stays elevated thereafter. This expression 
pattern along with the inhibitory effects observed on adipogenesis following over 
expression of C/EBPζ in cell culture systems shows that it plays important regulatory 
roles during adipogenesis (Darlington et al., 1998; Rangwala and Lazar, 2000; Ron and 
Habener, 1992; Rosen and Spiegelman, 2000)  
 
 The role of C/EBPβ and δ in the regulation of C/EBPα and PPARγ activity have been 
studied extensively (Darlington et al., 1998; Hamm et al., 2001; Lane et al., 1999; 
Rangwala and Lazar, 2000; Salma et al., 2006; Tanaka et al., 1997; Wu et al., 1996). 
C/EBPβ and δ directly activate C/EBPα and PPARγ2 through the C/EBP regulatory 
elements present in the proximal promoters of these genes (Lane et al., 1999) Studies 
conducted in transgenic mouse and primary pre-adipocyte cultures showed that disruption 
of C/EBPβ and δ genes prevents the normal development of adipose tissue and 
differentiation of cultured pre-adipocytes. Eventhough the absence of C/EBPβ and δ 
affects the normal development and differentiation of adipose tissue, its absence does not 
severely interfere with the activation of C/EBPα and PPARγ due to the presence of an 
alternative pathway involving activation of endogenous PPARγ ligads/activators (Hamm 
et al., 2001; Tanaka et al., 1997).  
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Sequential localization and binding of C/EBPα, β and δ to the consensus sequences 
present in the centromere is considered to be another regulatory mechanism associated 
with the mitotic events occurring during adipocyte differentiation. The first mitotic event, 
clonal expansion, is a prerequisite for adipocyte differentiation (Gregorie et al., 1998; 
Otto and Lane, 2005). C/EBPβ and δ, which are not anti-mitotic, localize at the 
centromere at the beginning of clonal expansion. During the clonal expansion phase, the 
expression of these proteins begins to decline and the levels of C/EBPα slowly increase. 
C/EBPα, which is anti-mitotic, reaches its peak concentration when clonal expansion 
ceases. Thus these three proteins together help the differentiating adipocytes to go 
through clonal expansion to terminal differentiation (Lane et al., 1999).  
 
Sterol regulatory element binding proteins (SREBPs) 
SREBPS are transcription factors that have been established as regulators of cholesterol 
and fatty acids metabolism. Biological activity of these proteins is controlled by the level 
of intracellular sterols. These membrane bound proteins are activated by the proteolytic 
cleavage of the N-terminal residue (Shimano, 2001). Active SREBPs enter cell nucleus 
and activate transcription of several genes involved in three major pathways involved in 
lipid metabolism viz. cholesterol biosynthesis, fatty acid uptake and cholesterol and fatty 
acid biosynthesis (Desvergne and Wahli, 1999; Shimano, 2001). SREBPS have been 
found to play important regulatory roles in adipogenesis by activating two isoforms of 
PPARγ, PPARγ1 andγ3 (Fajas et al., 1999). SREBPs control PPARγ expression by 
biding to two distinctive regulatory regions in its promoter, the E-box (CANNTG) and 
sterol regulatory element (SRE) (Fajas et al., 1999; Kim et al., 1998; Shimano, 2001). 
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Through the E-box motif, SREBP induces the expression of FAS and LPL, two key genes 
involved in fatty acid metabolism and its regulation (Fajas et al., 1999; Kim and 
Spiegelman, 1996). Here SREBP directly induces transcription of PPARγ and in turn the 
downstream target genes. Its action through SRE is more or less an indirect activation 
process. During this second process, activated SREBP induces the production of 
endogenous ligands that can bind and activate PPARγ proteins (Fajas et al., 1999; Kim et 
al., 1998). 
 
Adipose tissue - Significance in beef industry 
Adipose tissue growth and distribution in domestic animals are of great interest for 
various physiological, commercial and health related reasons. Adipose tissue functions as 
an energy store which can be mobilized during periods of negative energy balance. 
Additionally, in a normal growing animal, deposition of lipids indicates the energy needs 
of the animal and their ability to convert feed into meat. 
 
From a commercial stand point, in many countries including the United States, the 
amount of total fat accumulated in the carcass serves as a major determinant of its value 
at the time of slaughter. The United States Official Standards for Carcass Beef amended 
in 1939 consider fat as a major determinant of the grade description. According to the 
current grading system, carcass beef standards can be classified into two main grade 
groups: yield grades and quality grades. The characteristics of the meat, especially 
marbling and maturity, which predicts the tenderness, juiciness and flavor determines the 
USDA quality grades (prime, choice, select, standard etc.), while the yield grades (1 to 5) 
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are determined by the amount of external, kidney, pelvic and heart fat along with the area 
of ribeye, muscle and the carcass weight (United States Department of Agriculture, 
1997). The major functions attributed to the Federal Beef Grading System include, “aid 
to livestock producers in identifying and receiving prices commensurate with the quality 
and quantity of the livestock they produce, providing consumers, retailers, and 
institutions with a uniform supply of meat of the desired quality and assistance in the 
promotion and marketing of quality products” (United States Department of Agriculture, 
2006). The key participants in the chain of beef marketing, producers, packers, 
wholesalers and retailers, give great importance to the quality and yield grades because 
the products are either rewarded or discounted based on the amount of marbling and 
external fat present in the carcass (Wachenheim and Singley, 1999).  
 
According to the latest trends in marketing, the end users/consumers play the most 
significant part in deciding the position of beef industry in the highly competitive meat 
environment. Consequently, consumer preferences including demand for high quality 
beef which is suitable for evolving consumer life styles and price of beef compared to 
competing meat products like poultry and pork gained the attention of all participants of 
the meat marketing channel (Wachenheim and Singley, 1999). Over the past three 
decades (1970-2000) U.S. meat consumption pattern has changed dramatically. 
Consumers preferred poultry over beef and the per capita beef consumption has declined 
during this period from 79 to 64 percent (Haley, 2001). Several surveys and studies were 
conducted during the last 20 years to identify the major factors associated with this 
dramatic decline in the demand for beef. The results suggested that a combination of 
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factors rather than a single factor contributes to this significant loss. The most important 
factor was consumer’s preference for meat which is high in quality, healthy, easy to 
prepare and low in prices compared to other competing products on the market 
(Schroeder et al., 2000)  
 
During early to mid 1980s major changes in the beef industry occurred because of the 
finding that consumers are hesitant to buy beef with excessive external fat. In 1990 
National Cattlemen’s Association announced that the quality defects, excess fat and 
management problems accounted for a total loss of $5 billion or $192 per slaughtered 
steer and heifer, of which ~$ 4 billion came from excessive fat alone (Smith et al., 2000). 
It was necessary to determine the strength of these existing problems to reinstate the beef 
industry to where it was during 1970s.  
 
The first National Beef Quality Audit (NBQA) was awarded to scientists in 1991 in an 
effort to assess the quality of beef marketed in the U.S, to identify the vital problems and 
to develop different strategies to rectify them. The audit report concluded that even 
though there were great opportunities to reduce the total fat production significantly, 
“cattle have been fed to heavier weights with approximately the same degree of 
subcutaneous fat and with less marbling and fewer high quality grades today than in the 
1970s” (Lorenzen et al., 1993). The highest level quality grades (U. S. Prime and U. S. 
Choice) showed a 20% point decline in 17 years, at the same time the yield grade showed 
only 0.3 point reduction. The audit workshop came up with the following objectives to 
improve quality: (1) attack waste by reducing excessive external fat (2) enhance taste by 
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improving overall palatability, tenderness and by assuring sufficient marbling (3) 
improve management and (4) control weight (Savell, 2006). As per the recommendations 
of NBQA 1991, beef quality audits have been conducted every five years to review the 
progress achieved in quality, consistency and competitiveness of beef (Boleman et al., 
1998; McKenna et al., 2002). NBQA 1995 identified ten important factors directly 
contributing to the quality concerns and the majority of them (low overall uniformity and 
consistency of meat, low overall palatability, insufficient marbling, inadequate 
tenderness, excessive external and seam fat) were directly or indirectly linked to fat 
deposition.  Goals and strategies were developed by the audit workshop to improve beef 
quality over the next five years (Boleman et al., 1998). The 2000 audit compared the 
results of the previous two audits and the results revealed that the industry has 
accomplished improvements in ‘waste and weight but not in taste, tenderness or 
management’ during the period between 1991 and 1995 (McKenna et al., 2002; Smith et 
al., 2000). First among the eight strategies developed by the 1995 audit to improve 
quality, consistency, competitiveness and market share of beef was: “assist producers to 
use selection and management techniques to produce cattle that fit customer expectation 
for marbling, red meat yield and weight”. The third quality audit workshop has shown 
that the message to improve quality has finally reached at the producer level as indicated 
by an increase in consumer demand for beef from 1997 through 2000 (Mimert et al., 
2002) .  Even though the demand showed modest increase, the progress in quality 
attributes were slow. The challenges identified were analogous to those identified during 
the second audit. Once again the recognized goals were mostly linked with external and 
internal fat deposition and its effect on quality (McKenna et al., 2002; Smith et al., 2000). 
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Eventually, all three national beef quality audits pointed out the need for more research to 
identify the genetic basis of carcass merit and their application in animal breeding, 
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DIFFERENTIAL ANALYSIS OF GENE EXPRESSION DURING IN VITRO 





Development of adipose tissue from its precursor cells is known as adipogenesis. 
Adipose tissue in mammalian embryos arises from a pluripotent mesenchymal stem cell 
population which can differentiate into osteogenic, myogenic, chondrogenic and 
neurogenic lineages (Cornelius et al., 1994; Ntambi and Young-Cheul, 2000; Zuk et al., 
2002). Mesenchymal progenitor cells are also present in the supportive stroma of bone 
marrow and adipose tissues (Stromal Vascular Cells/SVCs) of adult mammals. It has 
been reported that these adult stem cells can be easily isolated and used as an alternative 
source of mesenchymal stem cells to study their lineage specific differentiation (Zuk et 
al., 2002). Irrespective of their origin, these stem cells get committed to specific lineages 
in vitro on exposure to appropriate chemical and environmental stimuli. Several factors 
that lead to commitment and differentiation of mesenchymal stem cells to adipose lineage 
have been identified. These factors include insulin, insulin like growth factor I, cAMP, 
glucocorticoids, triiodothyronine, growth hormone, prostaglandins, long chain fatty acids, 
among others (Sottile and Seuwen, 2000). The full complement of factors needed for 
differentiation into adipocytes vary depending on the type of cell culture and origin of 
pre-adipocytes (Ailhaud et al., 1992). A combination of insulin, cAMP and 
glucocorticoid is generally considered necessary for the differentiation of all types of pre-
adipocyte cell culture systems (Ailhaud et al., 1992; Sottile and Seuwen, 2000). 
Progenitor cells when grown to confluence and exposed to the right combination of 
adipogenic factors go through a stage of post confluent mitosis (clonal expansion), 
growth arrest and subsequent differentiation (Ntambi and Young-Cheul, 2000). These 
cellular changes are accompanied by complex changes in expression patterns of 
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numerous adipogenic transcription factors, signaling molecules, hormones, enzymes and 
other adipose related proteins (Feve, 2005). Even though the morphological and cellular 
events appear to be identical between different cell culture systems, the gene expression 
pattern and activated pathways differ with type of cell culture, species, origin, and 
culturing protocols. Most of this information on adipose tissue development has been 
drawn from rodent and human cell culture systems. Ruminants are physiologically and 
anatomically distinct from monogastric animals. The location and distribution of fat also 
shows considerable variation. Hence, it is logical to assume that the regulatory 
mechanisms and gene expression patterns might as well be different in the ruminant 
species. 
 
Very few studies on gene expression have been so far conducted to identify the key 
molecular pathways of bovine adipocyte differentiation. The studies were mainly 
performed to analyze the differential expression of known adipogenic transcription 
factors like peroxisome proliferator activated receptor gamma and CAAT/enhancer 
binding proteins during bovine adipogenesis (Wu et al., 2000; Yamada et al., 2007). 
Microarray technology is an ideal platform to investigate global gene expression profiles 
especially during cell growth and differentiation. The present study was conducted to 
understand gene expression changes occurring during bovine pre-adipocyte 
differentiation. Microarray experiments were conducted on primary cultures of 
subcutaneous pre-adipocytes using adipose tissue specific cDNA microarrays. One 
hundred and eleven array elements were found to be differentially expressed with a two 
fold change in expression in at least one of the time point comparisons. 
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Materials and Methods 
Animals and Tissue collection  
Tissue samples were collected from three crossbred steers between 20 and 25 months of 
age. Subcutaneous adipose tissue was removed aseptically from the neck region 
immediately after slaughter. Collected tissues were chopped into small pieces and 
maintained in ice cold Dulbecco’s Modified Eagles Medium (DMEM) containing 
100IU/ml penicillin, 100µg/ml streptomycin, 0.25µg/ml amphotericin-B and 500µg/ml 
gentamycin (transport media) until further processing.  
  
Isolation culture and differentiation of bovine pre-adipocytes 
Protocols for the generation of primary cultures and differentiation experiments were 
adapted with modifications from published literature (Torii et al., 1998; Wu et al., 2000). 
 
A sub-sample of fat tissue was transferred to fresh transport media and finely minced. 
The tissue was then subjected to an enzymatic disaggregation to disperse the individual 
cell types. Approximately 10g of finely minced tissue was incubated in DMEM 
containing 2mg/ml Type II collagenase, 4mg/ml BSA, 20mM HEPES, 100IU/ml 
penicillin, 100µg/ml streptomycin, 0.25µg/ml amphotericin-B and 500µg/ml gentamycin 
(Digestion medida) at 90 rpm and 37°C for 90min. The tissue digest was filtered 
sequentially through 250 micron and 100 micron filter assemblies to remove undigested 
tissue particles and other debris. The flow through was collected and centrifuged at 1000 
rpm for 10min. The cell pellet containing pre-adipocytes was washed twice with transport 
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media and then re-suspended in DMEM supplemented with 10% FBS, 100IU/ml 
penicillin, 100µg/ml streptomycin, and 0.25µg/ml amphotericin-B (Growth Media). The 
cells were seeded on six well tissue culture plates (Corning, NY, USA) at a concentration 
of 2.5x104cells/cm2 in a total volume of 2ml. The seeded plates were incubated in a 
humidified incubator maintained at a 5% CO2 atmosphere and 37°C. Cells were 
supplemented with fresh growth media every 48 h until subsequent sub-culture.  
Cells at fourth subculture were grown to confluence and induced with a differentiation 
media containing DMEM/Ham’s F12, 10% FBS, 100IU/ml penicillin, 100µg/ml 
streptomycin, and 0.25µg/ml amphotericin-B, 10µg/ml insulin, 0.25µM dexamethasone, 
0.25mM 3-iso-butyl-1-methylxanthine and 10% lyposin (Abbott Laboratories, Chicago, 
IL, USA) (induction mediaI). After 48h of differentiation the cells were maintained in 
induction media devoid of dexamethasone and 3-iso-butyl-1-methylxanthine (induction 
media II). 
 
Presence of lipid droplets in the cell cytoplasm was confirmed by Oil Red O staining of 
cells at 120h of differentiation. Oil Red O staining protocol was adapted with 
modifications from Ramirezzacarias et al. (1992). Briefly, following differentiation, 
media was aspirated from the cell culture plates and cells were washed three times with 
ice cold phosphate buffered saline solution (PBS). Cells were fixed in formalin for an 
hour and washed two more times with PBS. A stock solution of Oil Red O was prepared 
by dissolving 0.35g of stain in 100ml of Isopropyl alcohol. The solution was maintained 
at room temperature for 24h and filtered through a Whatman # 40 filter paper (Whatman 
International, Maidstone, England). A working solution of the stain was prepared by 
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adding 40ml of double distilled water to 60ml of the stock solution (60%). The working 
solution was placed in the refrigerator at 4°C for 24h and filtered twice using Whatman # 
40 filter paper. Staining was accomplished by treating the formalin fixed cells with the 
working solution of Oil Red O (10ml/75cm2 flask) for ~2h. After removing the stain, 
cells were rinsed extensively with double distilled water and air dried. Stained lipid 
droplets were observed using a phase contrast microscope.  
 
RNA isolation 
Three independent cell culture systems, representing three biological replicates, were 
maintained throughout the study. Total RNA was isolated from cells harvested at seven 
different time points (6, 12, 24, 48, 72, and 120h) using TRIzolTM reagent (Invitrogen, 
Carlsbad, CA, USA). Cells in TRizol were taken out from the freezer, thawed on ice and 
incubated at room temperature for 5min. Cells were then incubated in chloroform 
(0.2ml/mlof TRizol) for 3min and centrifuged at 4°C for 30min at 9000rpm. The aqueous 
phase was removed and transferred to a fresh tube. Isopropyl alcohol (0.5ml/ml 0f 
TRizol) was added to the aqueous phase and maintained at -80°C for one hour followed 
by centrifugation at 4°C for 15min at 9000rpm. Supernatant was discarded and the RNA 
pellet was dissolved in 500µl of DEPC treated water. This RNA was then subjected to a 
second phenol (pH 5.2):chloroform:isoamyl alcohol (25:24:1) extraction and purification. 
phenol:choroform:isoamyl alcohol mixture was added at 1:1 ratio to the RNA, mixed 
well and centrifuged at room temperature for 5min at 14,000rpm. The aqueous phase was 
collected in a fresh tube and RNA was precipitated by the addition of 0.1 volume of 3M 
sodium acetate and 2.5 volumes of ice cold absolute ethanol. The tubes were maintained 
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at -80°C for one hour to increase the efficiency of precipitation. The resulting RNA was 
collected by centrifuging the tubes at 4°C for 30min at 14,000rpm. RNA pellet was re-
suspended in 30µl of DEPC treated water are stored at -80°C. RNA quality was assessed 
by denaturing agarose gel electrophoresis and spectrophotometric analysis. 
 
Adipose tissue specific cDNA microarray 
A bovine cDNA library constructed from subcutaneous adipose tissue was used to 
generate an adipose tissue specific cDNA microarray. The library was sequenced and all 
the EST sequences were submitted to the GenBank (dbEST IDs and GenBank accession 
numbers are presented in supplementary table available at 
http://www.ansi.okstate.edu/faculty/desilva/papers/table.html. In order to annotate the 
library, the EST sequences were queried against the Bovine Peptide, Unigene, and nr 
GenBank data base (e-15) respectively. All unknown EST sequences were finally queried 
against the GenBank nr database (all organisms). A non-redundant set of 1089 clones 
from the library were selected to include in the array. 
 
PCR-amplified transcripts of selected genes were printed on the array and designated as 
probes.  Array printing procedures were adapted from published literature (Hegde et al., 
2000).  
 
The probes re-suspended in 3XSSC were spotted onto Corning® UltraGAPS™ Coated 
Slides (Corning, NY, USA) using GeneMachines® OmniGrid™ Micorarrayer (Genomic 
Instrumentation Services, San Carlos, CA). The print head on the microarrayer was 
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equipped with 16 print tips in a 4X4 fashion. Sub-arrays printed by a single print tip 
represented a block. Sixteen unique blocks were generated using the 4X4 print tip 
arrangement. Each sample was replicated twice within a block and each block was 
printed three times on a single slide to give a final 4X12 array design. This design 
ensured that each probe was replicated six times (two spots within a block X 3 blocks) in 
the microarray. The array also contained positive controls, negative controls and 
normalization controls. A pooled sample of cDNA, used to generate the cDNA library, 
represented the positive control. Printing buffer alone was used as the negative control. 
Three plant genes and three genes from the photosynthetic bacteria Synecocystis sp. 
served as normalization controls. The normalization controls were randomly distributed 
throughout the array. After printing, the slides were left in a humidified atmosphere 
inside the printing chamber for six to eight hours to facilitate probe attachment on to the 
slides and generate high quality, uniform spots. The slides were then baked at 80°C 
overnight and stored in vacuum desiccators at room temperature until hybridization. 
 
The microarray experiment was designed to have three biological replicates. Total RNA 
isolated from the SVC cultures derived from three individual crossbred steers represented 
the biological replicates. As explained in previously, the microarrays were fabricated to 
have six technical replicate spots representing each printed cDNA on a microarray slide. 
This design provided 18 (3 biological replicates X 6 technical replicates) different data 






The slides with the immobilized probes were taken out from the desiccator and rinsed in 
0.1% SDS for 4-5minutes to remove excess DNA. Slides were then rinsed in sterile 
ddH2O and incubated in a boiling water bath (97ºC) for 8 minutes to denature the double 
stranded DNA probes. Using a slidefuge (TeleChem International, Sunnyvale, CA, 
USA), the slides were dried and placed in a screwcap tube slide holder containing pre-
warmed pre-hybridization solution ( BlockIt microarray blocking solution TeleChem 
International, Sunnyvale, CA, USA ) and incubated at 49ºC for 4h. Slides were recovered 
from the pre-hybridization solution, rinsed with ddH2O, dried and kept inside a 49ºC 
incubator until hybridization. 
 
cDNA synthesis, labeling and hybridization 
cDNA synthesis, labeling and hybridization were accomplished using a 3DNA Array 900 
indirect labeling kit (Genispere, Hatfield, PA, USA) containing Alexa FlourTM546 
(green) and Alexa FlourTM647 (red) fluorophores with few modifications. 
 
For cDNA synthesis, three micrograms of total RNA from the reference and test samples 
were reverse transcribed in two separate tubes at 42ºC for 4h, using primers provided 
with the kit and reverse transcriptase (Superscript II RT, Invitrogen, Carlsbad, CA, USA).  
The primers used were oligo dT sequences with a unique 31mer attached to the 5’end, 
referred to as the capture sequence. The capture sequence in primers was different for 
reference and test samples. 
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The cDNAs thus prepared were then hybridized to the pre-hybridized microarray slides. 
The 3DNA indirect labeling method involved two sequential hybridization reactions. 
cDNA from the reference and test samples with unique capture sequences attached at the 
3’ end was used for the first hybridization. cDNA was mixed with hybridization buffer 
and applied to the pre-hybridized array under a cover slip, in a total volume of 85µl. 
These arrays were incubated at 49°C for 18h in a humidified hybridization chamber. 
Slides were then washed for 15min in 2XSSC/0.1%SDS buffer pre-warmed to 65ºC 
followed by washes in 2XSSC and 0.2XSSc for 15min each. The slides were finally 
rinsed with ddH2O and spin dried. In the second hybridization, capture reagent 
containing the fluorescent labeled complementary oligomer, specific for each cDNA 
population (reference sample labeled with green fluorophore and the test sample was 
labeled with red fluorophore) was hybridized to the unique capture sequence attached to 
the 3’ end. The capture reagent was prepared following kit protocol and applied to the 
array. The array was then incubated at 49ºC for 4h and washed and dried as explained 
before. The slides were stored in the dark until image acquisition. 
 
Hybridized slides were scanned with ScanArrayTM Express confocal laser scanner 
(PerkinElmer Life Sciences Inc., Bostom., MA). The intensity values for Alexa 
FlourTM546 and Alexa FlourTM647 channels for the foreground and background were 





Microarray data analysis 
Intensity values generated using GenePixTM Pro 4.0 were analyzed using several 
packages available in the Bioconductor Software Project (http://www.bioconductor.org/). 
Intensity estimates of the background and foreground for each spot were generated by 
GenePix Pro for both red and green channel. Background correction was then performed 
using Robust Multi-array Average (RMA) algorithm available in the 
Bioconductor/LIMMA package. After background correction, poor quality spots were 
removed by filtering. The threshold intensity value was set at 200 and any spots showing 
intensity of 200 or less in both channels were given low weight and removed from the 
downstream data analysis. Spots flagged as bad by GenePix were also filtered from 
further analysis. 
 
Two different kinds of normalization methods were adapted to account for the variation 
between spots within an array and variation between replicate arrays (biological 
replicates). The first method, Loess- within print tip group intensity dependent 
normalization, balanced the effect of variation associated with dye bias, spatial effects 
and the effect of each print tip group within each array. Quantile normalization was used 
to balance the effect of red and green intensity bias across arrays (Yang et al., 2002). 
After data pre-processing and normalization, the expression ratio M for a particular 
spot/gene (g) was calculated by the formula  
M = log2 (Rg/Gg),  
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where Rg and Gg represented the red and green intensities for gene “g”. The M value 
represented the abundance of genes in the red channel (treatment) compared to the green 
channel (reference).  
 
In this experiment we used Moderated T-test (t-value) to identify and rank genes which 
were differentially expressed. List of differentially expressed genes were generated and 
ranked based on the M value (log2 ratio) and P-value. Genes with M value ≥1.0 or ≤-1.0, 
and a P-value <0.01, were considered statistically significantly differentially expressed. 
 
Gene ontology analysis 
Gene ontology analysis of the differentially expressed genes was conducted with the help 
of Genome Function Integrated Discoverer (GFinder), a web tool designed for the gene 
ontology and pathway analysis of microarray expression available at 
http://www.medinfopoli.polimi.it/GFINDer/. The gene IDs of the differentially expressed 
genes were retrieved from the Entrez Gene data base at National Center for 
Biotechnology Information (NCBI) and were used for the ontology analysis.  
 
Quantitative Real Time PCR assay (qRT PCR) 
Expression data generated by microarray experiment was validated using qRT PCR 
assays. Two up-regulated genes (adipocyte type fatty acid binding protein[FABP4] and 
fatty acid translocase [FAT]) and one down-regulated gene (epithelial membrane protein 
3 [EMP3]) were selected for validation. Gene expression analysis was performed using 
two step SYBR green qRT PCR. In the first step, cDNA was synthesized from 1.5µg of 
total RNA in 20µl using random hexamers and reverse transcriptase (Applied 
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Biosystems, Foster City, CA, USA). Primers for the real time PCR were designed using 
Primer3 software package (Rozen and Skaletsky, 2000). Primer sequences and the 
annealing temperatures are presented in Table 1. In the second step, Real Time PCR 
assay was carried out in 15µl volume in MyiQ Real Time PCR detection system (Bio-
Rad Laboratories, Hercules,CA). Each 15µl reaction contained 7.5µl of 2X iQ™ SYBR® 
Supermix (Bio-Rad Laboratories, Hercules, CA), 400nM forward primer, 400nM reverse 
primer and 100-200ng of cDNA. Thermal cycling conditions were 95°C for 5min, 
followed by additional 40 cycles of 95°C for 10sec and 58 to 62°C for 30sec. After the 
PCR thermal cycling, melt curve analysis was conducted by bringing the reactions to 
55°C and increasing the temperature by 0.5°C up to 95°C. 18S ribosomal RNA was used 
as the house keeping gene for normalization. The assay was conducted as per 
manufacturer’s directions (18 S Ribosomal RNA kit, Eurogentec, Philadelphia, PA, 
USA). Relative gene expression analysis was performed following the comparative CT 
method published by Livak et al. (2001). Threshold cycles (CT) for the down stream 
relative expression analysis were set and detected during the geometric amplification 
phase of each reaction. The ∆CT value was calculated by subtracting the 18S ribosomal 
CT value of each sample from the corresponding gene CT values [∆CT = (Gene ∆CT)-(18S 
∆CT)]. To calculate the ∆∆CT value, the highest mean ∆CT value was taken as an 
arbitrary constant and was subtracted from all other mean ∆CT values. Fold change in 




Culture and differentiation of pre-adipocytes 
Bovine pre-adipocyte primary cell cultures were successfully established from SVCs 
isolated from subcutaneous adipose tissue. Cultured SVCs were morphologically similar 
to fibroblasts. On plating the cells at a concentration of 2.5x104cells/cm2, confluence was 
attained in 5 to 6 days (Fig. 1a). Adipocyte differentiation was induced, as described in 
the materials and methods section, by treatment of confluent cells with induction media I 
and II. Morphological changes from fibroblast like cells to round adipocytes could be 
observed starting as early as 12 h post-induction. Small lipid droplets were evident in the 
cytoplasm following 48 to 72 h of induction (Fig. 1b). The number and size of droplets 
increased from day two through day five of differentiation, at which time the cytoplasm 
was almost completely filled with lipid droplets (Fig. 1c). Presence of lipid droplets in the 
cytoplasm was confirmed by Oil Red O Staining (Fig. 1d).  
Adipogenesis was also confirmed at the molecular level based on the expression of fatty 
acid binding protein 4 (FABP4), a specific adipocyte differentiation marker 
(MacDougald and Lane, 1995). Relative gene expression changes of FABP 4 at different 
time points were determined by qRT- PCR analysis. A consistent up-regulation of the 







Bovine cDNA microarrays containing 1089 unique transcripts were used for this study. 
Relative gene expression levels at six different time points following induction of 
adipocyte differentiation were determined with respect to the gene expression at 0h of 
differentiation (confluent pre-adipocytes). One hundred and eleven array elements were 
found to be differentially expressed with a two fold change in expression in at least one 
of the time point comparisons. Of the 111 elements, 67 were significantly up-regulated 
and 44 were significantly down-regulated (P<0.01). Twelve genes did not match any of 
the NCBI data bases used for annotation of the cDNA library. Ten genes were classified 
under unknown ESTs since there were no annotations associated with them even though 
they had significant matches. Two of the unknown ESTs were matched to fat cDNA 
libraries (e-values 0 and 1 e-121, respectively). These two transcripts were consistently up-
regulated by more than two fold from 48h of differentiation. The remaining 88 elements 
corresponded to specific annotated genes in the NCBI database and were used for 
subsequent gene ontology analysis employing GFinder 




Based on the findings of gene ontology analysis, differentially expressed genes were 
grouped into 10 functional classes (Fig3). Gene description, dbEST ID, GenBank 
Accession number, Entrex gene ID and the M-values for these genes are presented in 
Table 2 and the M values and P values for all the genes on the array are presented in the 
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supplementary table (http://www.ansi.okstate.edu/faculty/desilva/papers/table.html). Ten 
genes involved in the metabolism, binding and transport of lipids as well as genes 
encoding proteins secreted from adipose tissue were grouped together (Fig3.A). 
Adipocyte type fatty acid binding protein (FABP4), fatty acid translocase (CD36) and 
Chemokine ligand 16 (CXCL16) were consistently up-regulated after 12h of 
differentiation. Acetyl CoA synthetase2 (ACSS2), Stearoyl CoA desaturase (SCD), 
homolog of yeast polyunsaturated fatty acid elongation factor (MGC 128086) and 
phosphatidic acid phosphatase (PPAP2B), all of which are involved in triacyl glycerol 
biosynthesis, were up-regulated from 48h through 120h and throughout post-induction. 
Other genes in this class included apolipoproteins like APOE and serum amyloid A3 
(SAA3), and caveolin 1 (CAV1). These three genes were also up-regulated at 48, 72 and 
120h time points post induction, respectively. 
Differentially expressed enzymes involved in the glycolytic pathways were grouped 
together (Fig 3.B). Among them, glucose phosphate isometase (GPI), enolase (ENO1) 
and transketolase (TKT) were found to be up-regulated and phosphoenolpyruvate 
carboxykinase 2 (PCK2) was found to be down-regulated.  
 
Genes coding for cytoskeletal and extracellular matrix (ECM) proteins were found to be 
differentially expressed and was most evident between 24 and 72h of adipocyte 
differentiation (Fig 3.C). Major cytosketal components like beta actin (ACTB), tubulin 
(TUBB) and vimentin (VIM) were down-regulated starting as early as 24 h post-
induction. Gelsolin (ADF), an actin filament depolymerizing factor, was up-regulated at 
the time points where actin was down-regulated, whereas, microfilament and actin 
 55 
filament cross linker protein (LOC506730) showed consistent down-regulation 
throughout the differentiation experiment. ECM components showing fluctuations in 
expression included four types of collagens (COL1A1, COL3A1, COL4A1 and 
COL5A2), nidogen (NID1), fibronectin (FN1) and milk fat globule-EGF8 protein 
(MFGE8). Expression of Types I, III and V collagen were down-regulated from 24 to 
72hpost-induction, while Type IV collagen was predominantly up-regulated. NID1 
showed a similar pattern of gene expression as COL4A1. Fibronectin (FN) did not show 
any significant fluctuations in expression during early phases, but was up-regulated in the 
mature adipocytes at 120h of differentiation. MFGE8, a major cell adhesion protein, was 
consistently down-regulated throughout differentiation.  
 
Genes involved in cell growth and differentiation were predominantly down-regulated 
except for cyclin fold protein 1 (MGC 165952) which showed consistent up-regulation 
from 12h post-induction (Fig. 3D). 
 
Among genes involved in transcription, only high mobility group box protein was down-
regulated. All others showed patterns of up-regulation (Fig 3.E). 
 
Oxidoreductases were another important category of genes that showed consistent up-
regulation (Fig. 3F). Except for plasma glutathione peroxidase (GPX3) eight of the 
differentially expressed oxido-reductase genes were up-regulated from 6h through 120h 




Genes involved in translation, protein synthesis and turn over were grouped together (Fig. 
3G). Proteases such as peptidase D (PEPD) and leucine amino peptidase 3 (LAP3) were 
up-regulated and pro-protein convertase subtilisin (PCSK7) was down-regulated. A 
serine/cysteine proteinase inhibitor Plasminogen activator inhibitor 1 (SERPINE1), was 
down-regulated from 24h through 120h post-induction. Two chaperon proteins, heat 
shock 70kDa protein 8 (HSPA8) and C1GALT1-specific chaperone 1(C1GALT1C1), 
also showed differential expression. HSPA8 was up-regulated during the early time 
points and C1GALT1C1 was up-regulated from 24 to 120h post-induction. Eukaryotic 
translation initiation protein 4A isoform1 (E1F4A1) was up-regulated at 6 and 12h post 
confluence and seryl tRNA synthetase (SARS) was down-regulated from 24 to 72h post 
induction.  
 
Another group showing differential expression included genes involved in signal 
transduction (Fig. 3H). Calmodulin 1, bitter taste receptor, RAS like protein rit and 
protein phosphatase 2 alpha were down-regulated at various time points during 
differentiation.  Genes like Tax1 binding protein, guanine nucleotide binding protein and 
protein tyrosine phosphatase 4a2 were predominantly up-regulated. Transporters 
differentially expressed during pre-adipocyte differentiation included ferritin, amino acid 
transporters, chloride ion transporters and nucleoside transporters (Fig 3I). 
 
 Differentially expressed genes that were not incorporated into any of the above 
categories were grouped in to a class named ‘others’ (Fig. 3J). 
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Validation of microarray data using qRT PCR 
Three differentially expressed genes were chosen for validation of microarray data. A 
comparison between the gene expression profiles determined based on microarray and 
real-time PCR experiments are shown in Figure 4. Adipocyte type fatty acid binding 
protein and fatty acid translocase that were found to be up-regulated based on microarray 
data, also showed the same pattern on the real-time PCR experiments. Similarly, 
epithelial membrane protein 3, which was consistently down-regulated in the microarray 









Figure 1. Microscopic images of Stromal Vascular Cells at different stages of 
differentiation 
(a). Confluent SVCs morphologically similar to fibroblasts (b). Differentiating adipocytes 
48h- cells started showing change in morphology by 12h and the lipid droplets were 
apparent by 48h post induction (c). Differentiating adipocytes 120h post induction- 















Figure 2. Relative changes in the expression pattern of adipocyte type fatty acid 
binding protein (FABP4) analyzed using real-time PCR.  
FABP4 is an early marker of adipocyte differentiation. Its expression increased from 6h 
through 72h post induction indicating that the cells are differentiating from pre-
adipocytes to adipocytes. Bars with different superscripts represent significant differences 









Figure 3. Heat maps showing various gene ontology categories up/down-regulated 
during bovine pre-adipocyte differentiation  
Differentially expressed genes were organized into ten functional categories using 
GFinder, a web tool designed for the gene ontology and pathway analysis of microarray 
expression available at http://www.medinfopoli.polimi.it/GFINDer/. These functional 
categories are presented in Figure 3A through 3J. Gene symbol/Locus ID is used to 
represent up/down-regulated genes in the heat map. Gene description, dbEST ID, 
GenBank Accession number, Entrex gene ID and the M-values for these genes are 
presented in Table 2. Gene expression data for each gene for all the time points (M-
values, t-values and P-values) are presented in the Supplementary Table 
(http://www.ansi.okstate.edu/faculty/desilva/papers/table.html). In the heat map, boxes 
colored with shades of red represent up-regulated genes and shades of green represent 














Figure 4. Validation of microarray data on FABP4, CD36 and EMP3 using real-
time PCR.analysis.  
Three differentially expressed genes (FABP4, CD36 and EMP3) were chosen for 
validation of microarray data. Graphs on the left show the log ratios obtained from the 
microarray experiments and the graphs on the right show the relative changes in gene 
expression observed in real-time PCR. For all three genes presented, fold change in 
expression was normalized to the highest value. The gene expression patterns in the 





Table 1. Primers used for the real-time PCR analysis 








FABP4-forward AAGCTGCACTTCTTTCTCACC 21 
FABP4-reverse GACCACACCCCCATTCAAAC 20 62°C 197bp NM_174314 
CD36-forward CAATGGAAAGGACGACATAAG 21 
CD36-reverse TGGAAATGAGGCTGCATCTGT 21 60°C 121bp NM_174010 
EMP3-forward TCATCCTCTGCTGTCTGTCCTT 22 
EMP3-reverse CCAGAATCTCTTCGGCATGAAT 22 60°C 159bp NM_001024562 
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Table 2. List of genes which are up/down-regulated during bovine pre-adipocyte differentiation.  












  6H 12H 24H 48H 72H 120H 
Adipose related                     
g4l23 Acetyl-CoA synthetase 2 46401399 ES345274 ACSS2 506459 0.19 0.47 0.43 1.09 0.57 0.91 
g4h03 Apolipoprotein E 46401312 ES345187 APOE 281004 0.00 0.01 0.22 0.62 1.27 1.11 
f7b22 Caveolin 1 46400688 ES344563 CAV1 281040 0.49 0.75 0.82 0.07 1.04 0.10 
a2f07 CD36 antigen 46400170 ES344045 CD36 518526 0.76 1.67 2.62 2.32 2.65 3.14 
g2j05 Chemokine (C-X-C motif) ligand 16 46401209 ES345084 CXCL16 511671 0.81 1.51 1.98 2.26 4.11 3.05 
f5e12 Fatty acid binding protein 4, adipocyte 46400286 ES344161 FABP4 281759 0.52 1.12 1.52 1.90 3.48 2.68 
a1e11 
Homolog of yeast long chain polyunsaturated fatty 
acid elongatio 46400023 ES343898 MGC128086  617293 0.15 0.38 0.76 1.26 0.59 0.55 
f8l24 Phosphatidic acid phosphatase type 2B 46400965 ES344840 PPAP2B  617707 0.02 0.19 0.44 0.72 1.47 0.72 
a1g09 Serum amyloid A 3 46400064 ES343939 SAA3 281474 -0.18 -0.10 0.13 1.14 1.08 0.44 
a1e12 Stearoyl-CoA desaturase 46400025 ES343900 SCD 280924 -0.02 0.19 0.47 0.87 1.01 0.85 
Carbohydrate metabolism                     
g1b05 Enolase 1 46401023 ES344898 ENO1 281141 0.24 0.63 1.03 0.92 1.01 0.75 
g4p13 Glucose phosphate isomerase 46401454 ES345329 GPI 280808 0.38 1.71 1.78 1.62 1.32 0.97 
f6a03 Phosphoenolpyruvate carboxykinase 2 46400519 ES344394 PCK2 282856 -0.40 -0.63 -0.18 -1.23 -0.70 -0.71 
a1e09 Transketolase 46400020 ES343895 TKT 445425 0.04 0.35 1.07 0.59 0.99 0.53 
Cytoskltal/Extracellular matrix related                     
a1h01 Actin, beta 46400070 ES343945 ACTB 280979 0.07 0.03 -1.26 -1.86 -0.84 0.22 
f5m18 Collagen alpha 1(III) chain precursor 46400452 ES344327 COL3A1 510833 0.01 -0.23 -0.96 -1.03 -1.03 -0.24 
a2a12 Collagen, type I, alpha 1 46400097 ES343972 COL1A1 282187 -0.30 -0.34 -0.53 -1.03 -1.11 -0.74 
a1h04 Collagen, type IV, alpha 1 46400074 ES343949 COL4A1 282191 0.59 0.44 0.51 1.91 1.56 1.28 
a1g04 Fibronectin 1 isoform 4 preproprotein isoform 5 46400056 ES343931 FN1 280794 0.12 -0.13 -0.42 -0.25 0.38 1.16 
f6k21 Gelsolin precursor 46400620 ES344495 ADF 535077 -0.07 0.01 0.64 0.91 2.20 0.61 
f5e20 
Microfilament and actin filament cross-linker 
protein 46400294 ES344169 LOC506730  506730 -0.92 -1.23 -1.10 -0.44 -1.18 -0.95 
f7g23 Milk fat globule-EGF factor 8 protein 46400729 ES344604 MFGE8 281913 -0.54 -0.57 -0.87 -2.02 -2.34 -2.69 
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g3c21 Myosin, light chain 6 50172305 EX656782 MYL6 281341 0.02 -0.30 -1.11 -1.61 -1.08 -0.38 
g4n11 Nidogen 1 46401421 ES345296 NID1 534319 -0.13 0.33 1.42 1.55 1.39 1.02 
f5g22 Procollagen alpha 2(V) 46400341 ES344216 COL5A2 782818 -0.27 -0.42 -1.55 -1.16 -1.41 -0.46 
f7k02 Tubulin 46400750 ES344625 TUBB 781412 0.29 0.33 -0.01 -1.14 -0.85 0.47 
g1g09 Vimentin 46401065 ES344940 VIM 280955 -0.04 -0.75 -0.74 -0.79 -1.01 -0.53 
Cell growth/Differentiation                     
f6d15 Cyclin fold protein 1 46400549 ES344424 LOC613711 613711 0.34 0.71 1.06 1.21 1.48 1.28 
f7o13 Cyclin-dependent kinases regulatory subunit 1 46400790 ES344665 MGC142665 615827 -0.08 -0.05 -0.03 -1.29 -0.46 -0.63 
f8j14 Cysteine-rich angiogenic inducer 61 46400936 ES344811 CYR61 508941 1.16 0.18 -0.79 -0.67 -0.68 -0.64 
f7n10 Cysteine-rich protein 2 46400774 ES344649 CRIP2 780821 -0.40 -0.83 -1.68 -1.56 -1.25 -0.82 
f5n03 Epithelial membrane protein 3 46400459 ES344334 EMP3 535273 -0.41 -1.33 -1.77 -1.80 -2.06 -0.96 
g4j21 Insulin-like growth factor binding protein 6 46401357 ES345232 IGFBP6 404186 -0.05 -0.28 -0.66 -0.74 -1.04 -1.16 
g1e16 Platelet-derived growth factor B 46401053 ES344928 PDGFB 540106 -0.72 -1.12 -0.77 -0.28 -0.73 0.02 
Transcription                     
f7k05 Cellular repressor of E1A-stimulated genes 46400752 ES344627 CREG/ 530908 -0.12 0.16 0.47 1.41 2.15 2.39 
f5i23 Cyclin L2 46400383 ES344258 CCNL2 538796 0.27 1.28 1.56 2.87 3.90 3.19 
g4i12 Forkhead box P1 46401333 ES345208 FOXP1 515903 0.11 0.43 1.07 0.66 0.86 0.36 
g4j03 Heterogeneous nuclear ribonucleoprotein F 46401343 ES345218 HNRPF 506917 0.05 -0.08 0.09 0.44 1.48 0.89 
f5m03 High mobility group box 46400440 ES344315 LOC782741  782741 -0.28 -0.99 -1.04 -0.72 -1.32 -0.80 
f5p23 Prothymosin alpha 46400518 ES344393 PTMA 615626 1.18 0.74 0.07 -0.64 -0.12 -0.01 
Oxidoreuctases                     
g4d19 Anti-oxidant protein 2 (Peroxoredoxin 6) 46401264 ES345139 AOP2/PRDX6 282438 1.21 1.13 1.17 0.55 0.79 0.64 
g1a05 Glutathione peroxidase (GPx) plasma isoform 46401015 ES344890 GPX3 281210 0.16 0.19 -0.14 0.31 1.52 1.50 
a1e10 Glutathione S-transferase M1 46400022 ES343897 GSTM1 327709 0.14 0.59 1.40 1.16 1.28 0.92 
f6k09 Microsomal glutathione S-transferase 1 46400617 ES344492 MGST1 493719 0.15 0.86 1.48 1.94 2.38 1.67 
f5k24 Peroxiredoxin 1 46400418 ES344293 PRDX1 281997 0.83 1.73 2.19 1.71 1.71 2.04 
f5l19 Peroxiredoxin 2 46400431 ES344306 PRDX2 286793 0.51 1.22 1.68 0.84 1.24 1.54 
g4k22 Thioredoxin 46401378 ES345253 TXN 280950 0.66 1.08 1.20 0.76 1.30 1.70 
f7n17 Xanthine oxidoreductase  46400778 ES344653 XDH 280960 1.14 0.97 1.08 0.81 0.75 0.38 
Signal transduction                     
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a2b11 Bitter taste receptor Bota-T2R65A 46400111 ES343986 T2R65A 664647 -0.44 -0.32 -0.47 -0.80 -1.20 -0.84 
f8g13 CALM1 protein 46400892 ES344767 LOC786304 786304 -0.27 -0.60 -0.73 -0.86 -1.32 -0.83 
f8e06 Guanine nucleotide binding protein 2 46400858 ES344733 GNG2 281203 -0.24 -0.21 1.11 0.24 -0.09 0.18 
g3o11 
Protein phosphatase 2, catalytic subunit, alpha 
isoform 50172327 EX656804 PPP2CA 282320 0.04 0.08 0.03 -1.21 0.00 0.08 
g2c06 Protein-tyrosine phosphatase, type IVA, member2 46401163 ES345038 PTP4A2 614435 1.34 1.95 2.32 3.20 4.64 3.84 
g4g20 Rit 46401307 ES345182 LOC533646 533646 -0.08 -0.13 -1.22 -1.28 -1.29 -0.32 
g4l22 T-cell leukemia virus type I binding protein 1 46401398 ES345273 TAX1BP1 535589 0.47 1.15 0.97 0.78 1.23 1.77 
Protein synthesis/Turn over                     
g4k13 C1GALT1-specific chaperone 1 46401372 ES345247 C1GALT1C1 531644 -0.06 0.64 1.93 2.07 1.66 1.33 
g4f06 Eukaryotic translation initiation factor 4A isoform 1 46401285 ES345160 EIF4A1 504958 1.21 0.87 -0.09 0.22 0.28 0.66 
f5b17 Heat shock 70kDa protein 8 46400231 ES344106 HSPA8 281831 2.61 0.80 0.20 -0.30 0.28 0.09 
f8k22 LAP3 protein 46400952 ES344827 LAP3  281271 -0.23 0.15 0.79 0.84 1.46 0.34 
a1d09 Peptidase D 46400005 ES343880 PEPD 615158 0.17 0.53 1.50 1.46 1.20 1.06 
g4j17 Plasminogen activator inhibitor 46401354 ES345229 SERPINE1 281375 0.79 0.26 -0.92 -1.32 -1.63 -1.32 
g4d21 Proprotein convertase subtilisin/kexin type 7 46401265 ES345140 PCSK7 515398 -0.47 -0.79 -1.35 -1.58 -1.30 -0.47 
g4k20 Seryl-tRNA synthetase 46401376 ES345251 SARS 281476 -0.19 -0.47 -0.84 -0.91 -1.23 -0.54 
Transporters                       
f5i12 Chloride intracellular channel 1 46400379 ES344254 CLIC1 515646 0.41 0.07 -0.22 -1.11 -0.81 -0.29 
a2g09 Ferritin, heavy polypeptide 1 46400190 ES344065 FTH1 281173 -0.12 0.44 1.27 1.32 1.21 1.18 
f6d16 Ferritin, light polypeptide 46400550 ES344425 FTL 286861 0.26 0.83 1.23 2.01 1.88 2.05 
f6c15 
Glycoprotein-associated amino acid transporter 
LAT2 46400534 ES344409 LAT2 536818 0.06 0.40 0.64 1.49 1.44 1.00 
f6p20 KIAA0755 protein 46400676 ES344551 SEC24D 504422 -0.10 -0.05 -0.61 -0.71 -0.20 -2.65 
a1d10 Solute carrier family 24 member 6 46400007 ES343882 SLC24A6  508887 0.21 0.65 1.49 1.30 1.02 1.10 
f8p01 Solute carrier family 29 46401004 ES344879 SLC29A1 510932 0.29 0.17 0.71 0.94 1.66 0.63 
a2a10 Solute carrier family 7 46400094 ES343969 SLC7A7 504220 -0.17 -0.42 -0.86 -1.05 -0.80 -0.33 
Others                       
f8c03 
BCL2/adenovirus E1B 19kDa interacting protein 3-
like 46400822 ES344697 BNIP3L 534615 -0.06 0.13 0.66 1.03 0.67 0.92 
f5n06 Complement factor B precursor 46400462 ES344337 MGC137125  514076 -0.15 0.10 0.40 0.94 1.18 0.82 
a2b12 Cytochrome P450 46400113 ES343988 MGC140495 541302 -0.64 -1.00 -1.04 -1.51 -2.17 -1.72 
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a2f02 F3 protein 46400160 ES344035 LOC784008 784008 0.01 0.07 0.31 1.09 0.32 0.29 
f5f05 Proliferating cell nuclear antigen 46400301 ES344176 MGC128125 515499 0.18 0.02 1.14 0.09 0.06 0.05 
f8c15 Secreted protein, acidic, cysteine-rich 46400831 ES344706 SPARC 282077 0.28 0.49 0.57 0.52 0.86 1.22 




In adult mammals, adipose tissue growth occurs through hypertrophy of adipocytes and 
hyperplasia of mesenchymal progenitor cells present in the vascular stroma. Adipose-
derived and embryonic mesenchymal cells from human and mouse have been used as 
model systems to understand regulation of adipogenesis (Ailhaud et al., 1992; Feve, 
2005; Rosen and Spiegelman, 2000; Sottile and Seuwen, 2000). These studies have 
helped to delineate the process of pre-adipocyte differentiation and its complex regulation 
at the transcriptional level. The anatomical location and distribution of fat decides the 
quality and value of the finished product, hence adipogenesis plays an important role in 
beef production. Even though adipogenesis is well studied in monogastric animals, only 
limited information is available on adipose tissue development and regulation in 
ruminants. Information on ruminant and monogastric pre-adipocyte differentiation and 
metabolic differences between bovine subcutaneous and intramuscular adipose depots 
indicate substantial species and depot specific differences in the regulatory mechanism 
that control adipogenesis (Smith et al., 2000). In this study we used bovine subcutaneous 
pre-adipocyte primary cultures and cDNA microarrays to identify gene expression pattern 
during bovine in vitro adipogenesis.  
 
Out of 1089 transcripts analyzed in this study, 111 transcripts were found to be 
differentially expressed between pre-adipocytes and adipocytes.  
Differentially expressed genes were divided into ten groups based on their molecular 
function. The first group included genes directly or indirectly associated with 
adipogenesis, fatty acid metabolism and transport. As expected, these genes were up-
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regulated in one or more than one time point studied in this experiment. Expression of 
genes involved in fatty acid and triglyceride biosynthesis like SCD, ACSS2 and PPAP2B 
coincided with the appearance of lipid droplets in the cytoplasm of differentiating pre-
adipocytes. These findings suggest that triglyceride synthesis starts approximately 2 to 3 
days post induction of pre-adipocyte differentiation. SCD is an enzyme that catalyzes the 
rate limiting step in the synthesis of unsaturated fatty acids from acetyl CoA (Kasturi and 
Joshi, 1982). It is considered to be a late marker of adipocyte differentiation.  Expression 
of SCD and several other genes involved in adipogenesis have been reported to be 
regulated by key transcription factors like C/EBP alpha and/or PPAR gamma (Sottile and 
Seuwen, 2000). PPAR gamma is a member of the family of ligand-activated nuclear 
hormone receptors and a well known adipogenic transcription factor. In the present study 
PPAR gamma transcripts did not show differential expression following induction of pre-
adipocytes. Similar findings have also been observed during bovine bone marrow derived 
adipocyte differentiation (Tan et al., 2006). It was suggested to be a result of slightly 
different transcriptional control mechanisms involved in bovine pre-adipocyte 
differentiation.  
 
Other adipose tissue specific genes found to be positively regulated by PPAR gamma 
included CD36 and FABP4. These genes were highly up-regulated as early as 12h post 
induction and continued to increase up to 72h. FABP4 is considered to be an early marker 
of differentiation and has been reported to be positively regulated as early as 24h post 
differentiation in 3T3L1 pre-adipocytes (Burton et al., 2004; Burton and McGehee, 2004; 
Hansen et al., 2004). However, FABP4 expression during bovine bone marrow derived 
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pre-adipocyte differentiation has been reported to be negatively regulated at 24h and 
positively regulated only at 6 days post induction (Tan et al., 2006). This indicates a 
possible difference in gene expression between pre-adipocytes derived from different 
anatomical locations. It is important to note that FABP4 polymorphisms are found to be 
associated with marbling and subcutaneous adipose tissue deposition in cattle and pig 
(Gerbens et al., 1998; Michal et al., 2006). Comparing pre-adipocytes from different 
anatomical locations will help to better understand the difference between these fat 
depots at the cellular and molecular level. CD36 is a membrane bound glycoprotein 
which regulates up-take of long chain fatty acids by adipocytes and muscle cells. In our 
experiments, along with FABP4, CD36 also showed an increased expression. Up-
regulation of CD36 has not been previously reported during bovine pre-adipocyte 
differentiation. Studies conducted in 3T3L1 cells showed positive regulation of both 
FABP4 and CD36 (Yang et al., 2007). 
 
CXCL-16 was another gene found to be up-regulated during adipocyte differentiation. 
Differential expressions of certain chemokines reported during human pre-adipocyte 
differentiation indicated a regulatory role of chemokines during adipocyte differentiation 
(Gerhardt et al., 2001). CXCL16 has two effects; it acts as receptor for oxidized low 
density lipoproteins in macrophages and also shows chemotactic activity. Both CXCL16 
and CD36 have been identified as receptors for lipoproteins in lipid laden macrophages 
(Minami et al., 2001; Shimaoka et al., 2000). This chemokine was highly up-regulated 
throughout the process of differentiation. It is possible that CXCL16 along with CD36 
served as receptors for the transport of lipoproteins from the media into the cell.  
 76 
Glycolytic pathway plays and important role in fatty acid biosynthesis by providing 
substrates and reducing equivalents. Up-regulation of genes involved in glycolytic 
pathways along with the genes involved in triglyceride synthesis indicates de-novo 
synthesis of fatty acids and triglycerides in the differentiating pre-adipocytes. During 
differentiation of 3T3L1 pre-adipocytes, expression of PCK increases during later stages 
of differentiation and is considered to be a late marker of adipocyte differentiation (Beale 
and Tishler, 1992). In contrast to 3T3L1 pre-adipocytes, differentiating bovine showed 
down-regulation of PCK at least during one of the time point comparisons. PCK is the 
major glyceroneogenic enzyme in adipose tissue which converts pyruvate to 
glycerophosphate for the synthesis of glycerol for the esterification of fatty acid into 
triacyl glycerol. 
 
Marked changes in cellular morphology of pre-adipocytes from fibroblast-like cells to 
round adipocytes is a major initial event occurring during adipogenesis. These 
morphological changes occur as a result of alterations in the ECM components and the 
rearrangement of the cytoskeletal network. These structural changes are essential for the 
communication between ECM and the nuclear matrix and acts as a signal for the 
activation of adipogenic transcription factors and genes necessary for terminal 
differentiation (Rodriguez Fernandez and Ben-Ze'ev, 1989; Sottile and Seuwen, 2000). In 
cell lines, induction results in down regulation of actin, tubulin, vimentin, type I and III 
collagen, fibronectin, poly-L-Lysine and integrins, where as type IV collagen, entactin 
and laminins show patterns of up-regulation (Brandes et al., 1993; Rodriguez Fernandez 
and Ben-Ze'ev, 1989; Sottile and Seuwen, 2000; Spiegelman and Farmer, 1982). 
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Expression patterns of collagens, actin, tubulin, vimentin and nidogen were comparable 
to that of other cell lines. However, fibronectin and integrin gene expression in bovine 
was different from the general pattern reported in other cell lines. Fibronectin has been 
reported to inhibit differentiation of 3T3L1 cell lines and found to be negatively regulated 
during differentiation (Rodriguez Fernandez and Ben-Ze'ev, 1989), indicating the 
importance of fibronectin in 3T3L1 differentiation. In our experiments, fibronectin and 
integrin were not differentially regulated during early stages of differentiation and 
fibronectin was up-regulated at 120h of differentiation. Alterations in the expression 
pattern of ECM and cytoskeltal components have also been reported during the 
differentiation of bone marrow derived bovine pre-adipocytes. Bone marrow derived 
bovine pre-adipocytes showed similarities and variations in expression pattern of ECM 
and cytoskeltal components as compared to adipose derived pre-adipocytes. Taken 
together all these results indicate the activation of slightly different pathways and 
regulatory mechanisms based on the source and origin of pre-adipocytes.  
 
Committed pre-adipocytes go through a stage of growth arrest at confluence. They should 
be exposed to appropriate combinations of mitogenic and adipogenic stimuli in order to 
continue with subsequent mitotic clonal expansion, a special growth arrest and terminal 
differentiation phases (Otto and Lane, 2005). Several hormones, cell cycle modulators 
and mitogenic factors have been reported to be either up or down- regulated during this 
early stage of differentiation. Expression patterns of these proteins largely depend on the 
type of primary culture and cell line used (Sottile and Seuwen, 2000). In the present study 
seven genes involved in cell proliferation and differentiation were found to be 
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differentially expressed. Six of this viz. platelet derived growth factor B (PGDFB), 
cyclin-dependent kinase regulatory subunit 1 (CKS1), cysteine-rich angiogenic inducer 
61 (CYR61), epithelial membrane protein 3 (EMP3), insulin-like growth factor binding 
protein 6 (IGFBP6) and cysteine rich protein 2 (CRIP2) were down-regulated. IGFs and 
IGFBPs are considered to be crucial regulators of pre-adipocyte differentiation. 
 
Supraphysiological concentrations of insulin used in the induction media acts through 
IGF signaling pathway and is involved in the initiation of differentiation (Otto and Lane, 
2005; Sottile and Seuwen, 2000). Previous studies showed that IGFBPs can modulate 
adipocyte differentiation and this could be agonistic or antagonistic (Boney et al., 1994; 
Sottile and Seuwen, 2000). Similarly, PGDFB also can have either inhibitory, stimulatory 
or no effect on pre-adipocyte differentiation (Sottile and Seuwen, 2000). CKS1 is a 
component of the CDC28 protein kinase which promotes mitosis by transcriptional 
activation of CDC20 (Morris et al., 2003). The down regulation of IGFBP6 along with 
the other modulators of cell proliferation after 12-24h of induction might be indicative of 
reduction in cell proliferation and mitogenic activity and initiation of differentiation. The 
only protein that was up-regulated under this functional category was cyclinY or cyclin 
fold protein 1, a protein involved in cell cycle progression. This protein was consistently 
up-regulated from 24h through 120h of differentiation. Very limited information is 
available regarding the function of this protein and its modulatory effect on cell cycle 
progression. Since it was highly up-regulated 24h post induction, i.e. after the clonal 
expansion phase, it could be acting as a modulator of other cyclins and mitogens. The 
gene expression pattern observed for cell cycle related proteins indicates that bovine 
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adipose derived pre-adipocytes enter the special growth arrest/differentiation between 12-
48h of differentiation. 
 
Transcription factors modulating pre-adipocyte differentiation have been studied 
extensively in a variety of mammalian pre-adipocyte cell culture systems. As mentioned 
before, PPAR and C/EBP families of transcription factors are factors that modulate 
adipogenesis in monogastric animals like mouse and human. None of the C/EBP family 
members were represented on our array. PPAR gamma was not found to be differentially 
regulated. Similar findings were also reported in bovine bone marrow derived pre-
adipocyte differentiation studies (Tan et al., 2006). Ohyama et al (1998) reported that 
PPAR gamma 2 is expressed in bovine adipose tissue and adipose derived pre-adipocyte 
primary cultures. The expression was reported to be increased during pre-adipocyte 
differentiation when the cells were induced with an exogenous PPAR gamma ligand.  
 
Cellular repressor of E1A stimulated genes (CREG) is an antagonist of adeno virus E1A 
protein. Adeno Virus E1A protein is known to act as a transcriptional activator and 
repressor which promotes cell proliferation and inhibits differentiation. CREG being an 
antagonist of E1A can act as a controller of cell differentiation (Veal et al., 1998). CREG 
has been reported to have the ability to rapidly induce differentiation in a variety of cell 
types including pluripotent mouse EC cells, monocytes, myeloid cells and vascular 
smooth muscle cells (Han et al., 2007). CREG was positively regulated in our 
experiments from 48 through 120h of differentiation, and it coincides with the 
appearance of fat droplets in the cytoplasm of differentiating cells. These findings 
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indicate that CREG acts as an important modulator of bovine pre-adipocyte 
differentiation by promoting differentiation. Other transcription associated genes 
modulated during this differentiation included forkhead box P1 (FOXP1), prothymosin 
alpha (PTMA), cyclin L2 (CCNL2), and heterogeneous nuclear ribonucleoprotien F 
(HNRPF). CCNL2 is an RNA polymerase II associated protein which functions as a 
regulator of pre-mRNA splicing (Yang et al., 2004). The direct mechanism of action of L 
cyclins (like CCNL2) is not completely elucidated. CCNL2 showed consistent up-
regulation starting as early as 12h post induction.  
 
Several oxido-reductases/antioxidant genes represented on the array showed consistent 
up-regulation during the differentiation process. Being a tissue that accumulates fat 
droplets in its cytoplasm, adipose tissue is inclined to be exposed to stress associated with 
lipid peroxidation and reactive oxygen species (ROS). Enzymatic and non-enzymatic 
cellular antioxidant defenses protect adipose tissue against ROS. Enzymes involved in 
redox metabolic pathways (associated with ROS neutralization) can modulate 
proliferation and differentiation. ROS released from mitochodria can act as anti-
adipogenic signaling molecules and prevent pre-adipocyte differentiation (Carriere et al., 
2003; Carriere et al., 2004; Galinier et al., 2006). Recent reports demonstrating the 
regulatory role of Xanthine Oxidoreductase (XDH) in 3T3L1 and GPX3 on bovine 
intramuscular pre-adiocyte differentiation also shows the involvement of antioxidants 
during pre-adipocyte differentiation (Cheung et al., 2007; Tadashi et al., 2006). It is also 
important to note that there is substantial difference in the expression pattern of several 
antioxidants between 3T3L1, human, bovine intramuscular, bovine bone marrow and 
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bovine subcutaneous pre-adipocyte cells (Tadashi et al., 2006; Tan et al., 2006). This 
highlights the difference in the regulatory mechanisms associated with pre-adipocyte 
differentiation among different species and specific fat depots within a species.  
In addition to the above mentioned transcripts, several other transcripts involved in signal 
transduction, protein synthesis/ turn over and transport were also found to be 
differentially regulated during bovine subcutaneous pre-adipocyte differentiation.  
 
Conclusion 
The present study gives an overview of gene expression changes associated with bovine 
adipose tissue derived pre-adipocyte differentiation. The majority of the differentially 
expressed genes were grouped under adipose associated, cytoskeletal and extracellular 
matrix components, oxido-reductases and transporters indicating the importance of the 
associated pathways in bovine adipogenesis. Differences in the expression pattern of 
several important genes observed in this study compared to the patterns reported in other 
cell culture systems indicate the existence of distinct regulatory mechanisms and 
pathways. More work needs to be conducted using whole genome arrays to obtain a more 
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